세계의 감염증 치료제 시장 보고서(2025년)

Infectious Disease Therapeutics Global Market Report 2025

US $ 4,490 ￦ 6,371,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,209,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,048,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

감염증 치료제 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.8%의 성장률로 1,965억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 투자 증가, 임상시험 연구 확대, 임상시험 수 증가, 감염 예방에 대한 관심 증가, 조기 진단에 대한 인식 증가, 인지도 향상, 자금 조달 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 파트너십, 제품 승인, 투자, 치료제 연구개발 등을 들 수 있습니다.

감염성 질환의 증가는 감염증 치료제 시장의 성장을 촉진할 것으로 예상됩니다. 감염성 질환은 박테리아, 바이러스, 곰팡이, 기생충, 프리온과 같은 유해한 미생물에 의해 유발되는 질병입니다. 이러한 질병의 증가는 기후 변화, 환경 파괴, 항균제 내성, 면역 체계의 약화, 인간과 동물의 상호작용 증가, 생태계의 불균형 등의 요인에 기인합니다. 감염증 치료제는 감염증 치료, 이환율 및 사망률 감소, 지역사회 내 및 집단 간 감염증 확산 억제에 필수적입니다. 예를 들어, 2023년 11월 미국 정부 기관인 질병통제예방센터(Centers for Disease Control and Prevention)는 2022년 미국에서 8,331명의 결핵 환자가 발생했으며, 발생률은 인구 10만 명당 2.5명이었다고 보고했습니다. 이는 2021년에 비해 환자 수가 5.9% 증가했고, 발병률은 5.5% 상승했음을 의미합니다. 따라서 전염병의 확산이 전염병 치료제에 대한 수요를 주도하고 있습니다.

감염 치료제 시장의 주요 업체들은 보다 효과적인 치료법 개발, 항균제 내성 대응, 제품 포트폴리오 확장, 신흥 감염 위협 대응을 위해 감염 치료제 개발에 전략적 투자를 하고 있습니다. 이러한 투자는 환자 예후를 개선하고, 미충족 의료 수요를 충족시키며, 감염증 통제 및 관리를 위한 세계 공중보건 노력에 기여하는 것을 목표로 하고 있습니다. 예를 들어, 영국의 헬스케어 기업 GSK는 2022년 6월 저소득 국가의 감염증에 적극적으로 대응하기 위해 10억 파운드(10억 9,000만 달러)를 투자할 것이라고 발표했습니다. 이 이니셔티브는 이들 지역에 불균형적으로 영향을 미치는 질병을 퇴치하기 위한 연구 개발 노력을 강화하는 것을 목표로 합니다. 고소득 국가와 중저소득 국가 간의 의료 연구 자금과 자원의 격차는 사람들의 건강을 공평하게 개선하기 위해 이러한 적극적인 투자의 시급성을 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 감염증 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 감염증 치료제 시장 : 성장률 분석
• 세계의 감염증 치료제 시장 실적 : 규모와 성장, 2019-2024
• 세계의 감염증 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 감염증 치료제 전체 시장(TAM)

제6장 시장 세분화

• 세계의 감염증 치료제 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 약물
• 백신
• 세계의 감염증 치료제 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 결핵
• HIV/에이즈
• 인플루엔자
• 간염
• 기타 질병
• 세계의 감염증 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원과 진료소
• 소매 약국
• 조사기관
• 기타 최종사용자
• 세계의 감염증 치료제 시장, 약물 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 항생제
• 항바이러스제
• 항진균제
• 항기생충제
• 기타 치료제(단클론항체, 면역조절제)
• 세계의 감염증 치료제 시장, 백신 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 불활화 백신
• 생약독화 백신
• 아단위 백신
• mRNA 백신
• DNA 백신
• 톡소이드 백신

제7장 지역별·국가별 분석

• 세계의 감염증 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 감염증 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 감염증 치료제 시장 : 경쟁 구도
• 감염증 치료제 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Thermo Fisher Scientific
• AstraZeneca
• Abbott Laboratories
• Novartis International AG
• Danaher Corporation
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Janssen Pharmaceutical
• Siemens Healthineers
• Moderna Inc.
• Becton
• Dickinson
• and Company
• Regeneron Pharmaceuticals Inc.
• Boehringer Ingelheim GmbH

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 감염증 치료제 시장 2029 : 새로운 기회를 제공하는 국가
• 감염증 치료제 시장 2029 : 새로운 기회를 제공하는 부문
• 감염증 치료제 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Infectious disease therapeutics encompass a range of treatments and interventions designed to combat illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. The primary goal of infectious disease therapeutics is to either eliminate the infectious agent from the body or to control its replication and spread, thereby alleviating symptoms, preventing complications, and ultimately promoting recovery.

The main types of infectious disease therapeutics include drugs and vaccines. Vaccines are biological preparations that stimulate the immune system to recognize and combat specific infectious agents. These therapeutics are utilized to address various diseases such as tuberculosis, HIV/AIDS, influenza, hepatitis, and others. They are accessed by various end-users including hospitals and clinics, retail pharmacies, research organizations, and others.

The infectious disease therapeutics market research report is one of a series of new reports from The Business Research Company that provides infectious disease therapeutics market statistics, including infectious disease therapeutics industry global market size, regional shares, competitors with an infectious disease therapeutics market share, detailed infectious disease therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease therapeutics industry. This infectious disease therapeutics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infectious disease therapeutics market size has grown strongly in recent years. It will grow from $141.08 billion in 2024 to $151.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, increasing incidence of viral diseases, growing awareness about diagnosis, rising demand for efficient and quick diagnostic testing, growing demand for cost-effective generic drugs, growing prevalence of infectious diseases, growing importance of antimicrobial stewardship.

The infectious disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $196.5 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing investments, expansion of clinical trial studies, increasing number of clinical trials, increasing focus on infectious disease prevention, increasing awareness about early diagnosis, growing awareness and funding. Major trends in the forecast period include partnerships, product approvals, investments, and research and developments in therapeutics.

The increasing prevalence of infectious diseases is expected to drive the growth of the infectious disease therapeutics market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, parasites, or prions. The rise in these diseases is attributed to factors such as climate change, environmental disruptions, antimicrobial resistance, weakened immune systems, greater human-animal interactions, and ecological imbalances. Infectious disease therapeutics are essential in treating infections, reducing morbidity and mortality, and controlling the spread of communicable diseases both within communities and across populations. For example, in November 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, the United States recorded 8,331 tuberculosis (TB) cases, with an incidence rate of 2.5 per 100,000 people. This represents a 5.9% increase in cases and a 5.5% rise in the incidence rate compared to 2021. Therefore, the growing prevalence of infectious diseases is driving the demand for infectious disease therapeutics.

Key players in the infectious disease therapeutics market are making strategic investments in infectious disease drugs to develop more effective treatments, combat antimicrobial resistance, expand their product portfolios, and address emerging infectious threats. These investments aim to improve patient outcomes, meet unmet medical needs, and contribute to global public health efforts to control and manage infectious diseases. For instance, in June 2022, GSK, a UK-based healthcare company, announced a £1 billion (USD 1.09 billion) investment to proactively address infectious diseases in lower-income countries. This initiative seeks to enhance research and development efforts to combat diseases that disproportionately affect these regions. The disparity in health research funding and resources between high-income and low- and middle-income countries underscores the urgency for such proactive investments to improve population health equitably.

In May 2022, OPKO Health, a US-based healthcare company, completed the acquisition of Modex Therapeutics for $300 million. This acquisition significantly bolstered OPKO's technology foundation and expanded its product pipeline into new therapeutic areas, particularly oncology and infectious diseases. Modex Therapeutics, a US-based biotechnology company, specializes in manufacturing infectious disease therapeutics.

Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.

North America was the largest region in the infectious disease therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease therapeutics market consists of sales of antibiotics, antivirals, and immunotherapies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infectious disease therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Drugs; Vaccines
• 2) By Disease: Tuberculosis; HIV/AIDS; Influenza; Hepatitis; Other Diseases
• 3) By End-User: Hospitals And Clinics; Retail Pharmacies; Research Organizations; Other End Users
• Subsegments:

1) By Drugs - Antibiotics; Antivirals; Antifungals; Antiparasitics; Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)

2) By Vaccines - Inactivated Vaccines; Live Attenuated Vaccines; Subunit Vaccines; Mrna Vaccines; Dna Vaccines; Toxoid Vaccines

• Companies Mentioned: Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.;
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infectious Disease Therapeutics Market Characteristics

3. Infectious Disease Therapeutics Market Trends And Strategies

4. Infectious Disease Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Infectious Disease Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Infectious Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Infectious Disease Therapeutics Market Growth Rate Analysis
• 5.4. Global Infectious Disease Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Infectious Disease Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Infectious Disease Therapeutics Total Addressable Market (TAM)

6. Infectious Disease Therapeutics Market Segmentation

• 6.1. Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Vaccines
• 6.2. Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tuberculosis
• HIV/AIDS
• Influenza
• Hepatitis
• Other Diseases
• 6.3. Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Retail Pharmacies
• Research Organizations
• Other End Users
• 6.4. Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antivirals
• Antifungals
• Antiparasitics
• Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
• 6.5. Global Infectious Disease Therapeutics Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• Subunit Vaccines
• mRNA Vaccines
• DNA Vaccines
• Toxoid Vaccines

7. Infectious Disease Therapeutics Market Regional And Country Analysis

• 7.1. Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease Therapeutics Market

• 8.1. Asia-Pacific Infectious Disease Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease Therapeutics Market

• 9.1. China Infectious Disease Therapeutics Market Overview
• 9.2. China Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease Therapeutics Market

• 10.1. India Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease Therapeutics Market

• 11.1. Japan Infectious Disease Therapeutics Market Overview
• 11.2. Japan Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease Therapeutics Market

• 12.1. Australia Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease Therapeutics Market

• 13.1. Indonesia Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease Therapeutics Market

• 14.1. South Korea Infectious Disease Therapeutics Market Overview
• 14.2. South Korea Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease Therapeutics Market

• 15.1. Western Europe Infectious Disease Therapeutics Market Overview
• 15.2. Western Europe Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease Therapeutics Market

• 16.1. UK Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease Therapeutics Market

• 17.1. Germany Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease Therapeutics Market

• 18.1. France Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease Therapeutics Market

• 19.1. Italy Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease Therapeutics Market

• 20.1. Spain Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease Therapeutics Market

• 21.1. Eastern Europe Infectious Disease Therapeutics Market Overview
• 21.2. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease Therapeutics Market

• 22.1. Russia Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease Therapeutics Market

• 23.1. North America Infectious Disease Therapeutics Market Overview
• 23.2. North America Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease Therapeutics Market

• 24.1. USA Infectious Disease Therapeutics Market Overview
• 24.2. USA Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease Therapeutics Market

• 25.1. Canada Infectious Disease Therapeutics Market Overview
• 25.2. Canada Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease Therapeutics Market

• 26.1. South America Infectious Disease Therapeutics Market Overview
• 26.2. South America Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease Therapeutics Market

• 27.1. Brazil Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease Therapeutics Market

• 28.1. Middle East Infectious Disease Therapeutics Market Overview
• 28.2. Middle East Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease Therapeutics Market

• 29.1. Africa Infectious Disease Therapeutics Market Overview
• 29.2. Africa Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Infectious Disease Therapeutics Market Competitive Landscape
• 30.2. Infectious Disease Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease Therapeutics Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific
• 31.2. AstraZeneca
• 31.3. Abbott Laboratories
• 31.4. Novartis International AG
• 31.5. Danaher Corporation
• 31.6. GlaxoSmithKline plc
• 31.7. Gilead Sciences Inc.
• 31.8. Janssen Pharmaceutical
• 31.9. Siemens Healthineers
• 31.10. Moderna Inc.
• 31.11. Becton
• 31.12. Dickinson
• 31.13. and Company
• 31.14. Regeneron Pharmaceuticals Inc.
• 31.15. Boehringer Ingelheim GmbH

32. Global Infectious Disease Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease Therapeutics Market

34. Recent Developments In The Infectious Disease Therapeutics Market

35. Infectious Disease Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Infectious Disease Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Infectious Disease Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Infectious Disease Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료